Keyphrases
Mycosis Fungoides
100%
Immunomodulatory Effect
100%
Cytokine Profile
100%
AS101
100%
Peripheral Blood Mononuclear Cells
85%
Interleukin-10
42%
Interleukin-2
42%
Interleukin-5 (IL-5)
42%
Interferon-α (IFN-α)
28%
IL-2 Receptor
28%
No Significant Difference
14%
Two-level
14%
Age-matched
14%
Enzyme-linked Immunosorbent Assay (ELISA)
14%
Healthy Donors
14%
Malignant Neoplasms
14%
Treatment Initiation
14%
Soluble interleukin-2 Receptor (sIL-2R)
14%
Therapeutic Benefits
14%
Immunomodulating
14%
Phytohemagglutinin
14%
Lymphokines
14%
Tellurium
14%
CD4 T Cells
14%
Cutaneous Malignant
14%
Medicine and Dentistry
Cytokine
100%
Mycosis fungoides
100%
Ammonium Trichloro(dioxyethylene O,o')tellurate
100%
Peripheral Blood Mononuclear Cell
85%
Interleukin 10
42%
Interleukin 2
42%
Interferon
28%
Interleukin 5 Receptor
28%
Malignant Neoplasm
14%
Enzyme Linked Immunosorbent Assay
14%
Phytohaemagglutinin
14%
T-Helper Cell
14%
Interleukin 2 Receptor
14%
Lymphokine
14%
Interleukin 5
14%
Immunology and Microbiology
Cytokine
100%
Peripheral Blood Mononuclear Cell
100%
Interleukin 10
50%
Interleukin 2
50%
Interleukin 5
50%
interferon
33%
IL-2 Receptor
33%
T-Helper Cell
16%
Phytohaemagglutinin
16%
Enzyme-Linked Immunosorbent Assay
16%
Lymphokine
16%
Interleukin 2 Receptor
16%